Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases
复制标题
DOI:
10.1016/j.expneurol.2007.03.002
复制
发表时间:
2007-06-01
影响因子:
5.3
通讯作者:
Yamada, Masahito
中科院分区:
文献类型:
--
作者:
Ono, Kenjiro;Hirohata, Mie;Yamada, Masahito
The aggregation of alpha-synuclein (alpha S) has been implicated as a critical step in the development of Lewy body diseases (LBD) and multiple system atrophy (MSA). Both retrospective and prospective epidemiological studies have consistently demonstrated an inverse association between cigarette smoking and Parkinson's disease (PD). We used fluorescence spectroscopy with thioflavin S, electron microscopy and atomic force microscopy to examine the effects of nicotine, pyridine, and N-methylpyrrolidine on the formation of alpha S fibrils (f alpha S) from wild-type alpha S (alpha S (WT)) and A53T mutant alpha S (A53T) and on preformed f alpha Ss. Nicotine dose-dependently inhibited the f alpha S formation from both alpha S (WT) and A53T. Moreover, nicotine dose-dependently destabilized preformed f alpha Ss. These effects of nicotine were similar to those of N-methylpyrroli dine. The anti-fibrillogenic activity of nicotine may be exerted not only by the inhibition of f alpha S formation but also by the destabilization of preformed f alpha S. Additionally, this effect may be attributed to N-methylpyrrolicline moieties of nicotine. (c) 2007 Elsevier Inc. All rights reserved.